Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients

Journal of Bone and Joint Surgery - Series B

Volumn 90, Issue 12, 2008, Pages 1617-1622

  Axelrad, T W ^a   Steen, B ^a   Lowenberg, D W ^a,b   Creevy, W R ^a   Einhorn, T A ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOGENIC PROTEIN 1; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT OSTEOGENIC PROTEIN 1;

ADULT; ARTICLE; BONE RADIOGRAPHY; CASE REPORT; CAST APPLICATION; CLINICAL FEATURE; DEBRIDEMENT; FEMALE; HETEROTOPIC OSSIFICATION; HUMAN; HUMERUS FRACTURE; INTRAMEDULLARY NAILING; MALE; OPEN REDUCTION; PELVIS FRACTURE; PRIORITY JOURNAL;

ADULT; BONE MATRIX; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; FEMALE; HUMANS; HUMERAL FRACTURES; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; POSTOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 57149094500     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.90B12.20975     Document Type: Article

References (52)

1. Dimitriou R, Dahabreh Z, Katsoulis E, et al. Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury 2005;36(Suppl 4):51-9.
2. Giannoudis PV, Tziopis C. Clinical applications of BMP-7: the UK perspective. Injury 2005;36(Suppl 3):47-50.
3. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg [Am] 2001;83-A(Suppl 1):151-8.
4. Burkhart KJ, Rommens PM. Intramedullary application of bone morphogenetic protein in the management of a major bone defect after an Ilizarov procedure. J Bone Joint Surg [Br] 2008;90-B:806-9.
5. Vaccaro AR, Whang PG, Patel T, et al. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. Spine J 2007;8:457-65.
6. Giannoudis PV, Psarakis S, Kanakaris NK, Pape HC. Biological enhancement of bone healing with bone morphogenetic protein-7 at the clinical setting of pelvic girdle non-unions. Injury 2007;38(Suppl 4):43-8.
7. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg [Am] 2002;84-A:2123-34.
8. Gustillo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg [Am] 1976;58-A:453-8.
9. Swiontkowski MF, Aro HT, Donell S, et al. Recombinant human bone morphogenetic protein-2 in open tibial fractures: a subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg [Am] 2006;88-A:1258-65.
10. Axelrad TW, Kakar S, Einhorn TA. New technologies for the enhancement of skeletal repair. Injury 2007;38(Suppl 1):49-62.
11. Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an update. Injury 2005;36(Suppl 3):20-7.
12. Jensen TB, Overgaard S, Lind M, et al. Osteogenic protein-1 increases the fixation of implants grafted with morcellised bone allograft and ProOstean bone substitute: an experimental study in dogs. J Bone Joint Surg [Br] 2007;89-B:121-6.
13. Watanabe K, Tsuchiya H, Sakurakichi K, Tomita K. Bone transport using hydroxyapatite loaded with bone morphogenetic proteins in rabbits. J Bone Joint Surg [Br] 2007;89-B:1122-9.
14. Shields LB, Raque GH, Glassman SD, et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 2006;31:542-7.
15. Wysocki RW, Cohen MS. Ectopic ossification of the triceps muscle after application of bone morphogenetic protein-7 to the distal humerus for recalcitrant nonunion: a case report. J Hand Surg [Am] 2007;32:647-50.
16. Helfet DL, Kloen P, Anand N, Rosen HS. Open reduction and internal fixation of delayed unions and nonunions of fractures of the distal part of the humerus. J Bone Joint Surg [Am] 2003;85-A:33-40.
17. Kransdorf MJ, Meis JM, Jelinek JS. Myositis ossificans: MR appearance with radiologic-pathologic correlation. AJR Am J Roentgenol 1991;157:1243-8.
18. Kumagai K, Motomura K. Egashira M, et al. A case of progressive osseous heteroplasia: a first case in Japan. Skeletal Radiol 2008;37:563-7.
19. Kaplan FS, Glaser DL, Hebela N, Shore EM. Heterotopic ossification. J Am Acad Orthop Surg 2004;12:116-25.
20. Schmidt AH, VIncent KA, Aiona MD. Hemimelic progressive osseous heteroplasia: a case report. J Bone Joint Surg [Am] 1994;76-A:907-12.
21. Wainwright AM, Williams JR, Carr AJ. Interobserver and intraobserver variation in classification systems for fractures of the distal humerus. J Bone Joint Surg [Br] 2000;82-B:636-42.
22. Ahrengart L. Periarticular heterotopic ossification after total hip arthroplasty: risk factors and consequences. Clin Orthop 1991;263:49-58.
23. Chan ED, Morales DV, Welsh CH, McDermott MT, Schwarz MI. Calcium deposition with or without bone formation in the lung. Am J Respir Crit Care Med 2002;165:1654-69.
24. Lai HJ, Jao SW, Lee TY, Ou JJ, Kang JC. Heterotopic mesenteric ossification after total colectomy for bleeding diverticulosis of the colon: a rare case report. J Formos Med Assoc 2007;106(2 Suppl):32-6.
25. Mohler ER 3rd, Gannon F, Reynolds C, et al. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522-8.
26. Tanaka H, Nagai E, Murata H, et al. Involvement of bone morphogenetic protein-2 (BMP-2) in the pathological ossification process of the spinal ligament. Rheumatology (Oxford) 2001;40:1163-8.
27. Toyran S, Lin AY, Edward DP. Expression of growth differentiation factor-5 and bone morphogenetic protein-7 in intraocular osseous metaplasia. Br J Opthalmol 2005;89:885-90.
28. Cowan CM, Jiang X, Hsu T, et al. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts. J Bone Miner Res 2007;22:918-30.
29. Kaplan FS, Glaser DL, Shore EM, et al. Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg [Am] 2007;89-A:347-57.
30. Karunakar MA, Sen A, Bosse MJ, et al. Indometacin as prophylaxis for heterotopic ossification after the operative treatment of fractures of the acetabulum. J Bone Joint Surg [Br] 2006;88-B:1613-17.
31. Knelles D, Barthel T, Karrer A, et al. Prevention of heterotopic ossification after total hip replacement: a prospective, randomised study using acetylsalicyclic acid, indomethacin and fractionale or single-dose irradiation. J Bone Joint Surg [Br] 1997;79-B:596-602.
32. Board TN, Karva A, Board RE, Gambhir , Porter ML. The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty. J Bone Joint Surg [Br] 2007;89-B:434-40.
33. Estrores IM, Harrington A, Banovac K. C-reactive protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury. J Spinal Cord Med 2004;27:434-7.
34. Saudan M, Saudan P, Perneger T, et al. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial. J Bone Joint Surg [Br] 2007;89-B:155-9.
35. Karunakar MA, Sen A, Bosse MJ, et al. Indometacin as prophylaxis for heterotopic ossification after the operative treatment of fractures of the acetabulum. J Bone Joint Surg [Br] 2006;88-B:1613-17.
36. Shehab D, Elgazzar AH, Collier BD. Heterotopic ossification. J Nucl Med 2002;43:346-53.
37. Yu JK, Chiu FY, Feng CK, Chung TY, Chen TH. Surgical treatment of displaced fractures of posterior column and posterior wall of the acetabulum. Injury 2004;35:766-70.
38. Larson JM, Michalski JP, Collacott EA, et al. Increased prevalence of HLA-B27 in patients with ectopic ossification following traumatic spinal cord injury. Rheumatol Rehabil 1981;20:193-7.
39. Garland DE, Alday B, Venos KG. Heterotopic ossification and HLA antigens. Arch Phys Med Rehabil 1984;65:531-2.
40. Wildburger R, Zarkovic N, Egger G, et al. Comparison of the values of basic fibroblast growth factor determined by an immunoassay in the sera of patients with traumatic brain injury and enhanced osteogenesis and the effects of the same sera on the fibroblast growth in vitro. Eur J Clin Chem Clin Biochem 1995;33:693-8.
41. Eid K, Labler L, Ertel W, Trentz O, Keel M. Systemic effects of severe trauma on the function and apoptosis of human skeletal cells. J Bone Joint Surg [Br] 2006;88-B:1394-400.
42. Ring D, Jupiter JB. Operative release of complete ankylosis of the elbow due to heterotopic bone in patients without severe injury of the central nervous system. J Bone Joint Surg [Am] 2003;85-A:849-57.
43. Tsionos I, Leclercq C, Rochet JM. Heterotopic ossification of the elbow in patients with burns: results after early excision. J Bone Joint Surg [Br] 2004;86-B:396-403.
44. Dornberg JN, van Duijn PJ, Linzel D, et al. Surgical treatment of intra-articular fractures of the distal part of the humerus: functional outcome after twelve to thirty years. J Bone Joint Surg [Am] 2007;89-A:1524-32.
45. McAuliffe JA, Wolfson AH. Early excision of heterotopic ossification about the elbow followed by radiation therapy. J Bone Joint Surg [Am] 1997;79-A:749-55.
46. Garland DE, O'Hollaren RM. Fractures and dislocations about the elbow in the head-injured adult. Clin Orthop 1982;168:38-41.
47. Doornberg JN, van Duijn PJ, Linzel D, et al. Surgical treatment of intra-articular fractures of the distal part of the humerus: functional outcome after twelve to thirty years. J Bone Joint Surg [Am] 2007;89-A:1524-32.
48. Helfet DL, Schmeling GJ. Bicondylar intraarticular fractures of the distal humerus in adults. Clin Orthop 1993;292:26-36.
49. Kundel K, Braun W, Wieberneit J, Ruter A. Intraarticular distal humerus fractures: factors affecting functional outcome. Clin Orthop 1996;332:200-8.
50. Kawai M, Bessho K, Maruyama H, Miyazaki J, Yamamoto T. Human BMP-2 gene transfer using transcutaneous in vivo electroporation induced both intramembranous and endochondral ossification. Anat Rec A Discov Mol Cell Evol Biol 2005;287:1264-71.
51. Kawai M, Bessho K, Maruyama H, Miyazaki J, Yamamoto T. Simultaneous gene transfer of bone morphogenetic protein (BMP)-2 and BMP-7 by in vivo electroporation induces rapid bone formation and BMP-4 expression. BMC Musculoskelet Disord 2006;7:62.
52. Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 2006;31:2813-19.